Perfil
Fundador de Magellan Diagnostics, Inc., Michael F. Bigham es un empresario que ha estado al frente de 6 empresas diferentes y actualmente es Presidente Ejecutivo de Paratek Pharmaceuticals, Inc. También forma parte del consejo de administración de Adamas Pharmaceuticals, Inc., Inmediata Health Group (antiguo presidente), inMediata Corp. y Frazier Lifesciences Acquisition Corp. En el pasado ocupó el cargo de director financiero y vicepresidente ejecutivo de operaciones en Gilead Sciences, Inc., socio ejecutivo de Abingworth Management Ltd. y socio de Abingworth LLP (una filial de Abingworth Management Ltd.), presidente y director ejecutivo de Paratek Pharmaceuticals, Inc, Presidente de Magellan Diagnostics, Inc., Director de Avila Therapeutics, Inc., Presidente y Director General de Coulter Pharmaceuticals, Inc. y Socio y Co-Director de Banca de Inversión en el Sector Sanitario de Hambrecht & Quist Group, Inc. Se licenció en la Universidad de Virginia y obtuvo un MBA en la Universidad de Stanford.
Cargos activos de Michael Bigham
| Empresas | Cargo | Inicio |
|---|---|---|
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Director/Miembro de la Junta | - |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michael Bigham.
| Empresas | Cargo | Fin |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Director Ejecutivo | 25/06/2019 |
| ADAMAS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 24/11/2021 |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 01/11/2015 |
| SUPERNUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 23/12/2013 |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Director Ejecutivo | 01/01/2012 |
Formación de Michael Bigham.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 27 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Hambrecht & Quist Group, Inc.
Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Provides real time in-vivo imaging services | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Avedro, Inc.
Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Magellan Diagnostics, Inc.
Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Valeritas, Inc.
Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Inmediata Health Group
Inmediata Health Group Electronic Production EquipmentElectronic Technology Offers electronic solutions for enhancing the efficiency and the quality of health and dental care | Electronic Technology |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
inMediata Corp.
inMediata Corp. Regional BanksFinance Provides payment reconciliation solutions | Finance |
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Health Technology |
Magellan Biosciences, Inc.
Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Health Technology |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Technology Services |
Frazier Lifesciences Acquisition Corp.
Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Bolsa de valores
- Insiders
- Michael Bigham
















